INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

INMInMed Pharmaceuticals Inc.

CIK 0001728328

EDGAR filingsOpen in network
Disclosed transactions15
Buys / sells15 / 0
Max Insider Score47
Connections3with evidence

INM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$5.28
4 sh
Oct 23, 2026Oct 27, 2026
traded Oct 23, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    ADAR1 Capital Management, LLC10% Owner · May 21, 2026
  • ← Insider ofevidence
    Schneeberger Daniel10% Owner · May 21, 2026
22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY
$1,434
1,086 sh
Oct 19, 2026
Oct 20, 2026
traded Oct 19, 2026
+1d
SEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$1.32
1 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$1,301
984 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$750
564 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$11K
8,021 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$2,997
2,256 sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$7,436
5,601 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$4,051
3,046 sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC FORM 4

Evidence

25
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$11K
8,340 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC FORM 4

Evidence

25
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$37K
28.5K sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC FORM 4

Evidence

32
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$70K
54.3K sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC FORM 4

Evidence

43
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$300K
200.0K sh
May 19, 2026May 21, 2026
traded May 19, 2026
+2dSEC FORM 4

Evidence

47
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$312K
200.0K sh
May 19, 2026May 21, 2026
traded May 19, 2026
+2dSEC FORM 4

Evidence

40
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$110K
68.6K sh
May 19, 2026May 21, 2026
traded May 19, 2026
+2dSEC FORM 4

Evidence